Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Lyell Immunopharma revenue
Lyell Immunopharma's revenue is $61,000.
What is Lyell Immunopharma's revenue?
- Lyell Immunopharma's revenue growth from 2020 to 2024 is -99.21%.
- Lyell Immunopharma has 256 employees, and the revenue per employee ratio is $238.
- Lyell Immunopharma's peak quarterly revenue was $48.4M in 2022(q4).
- Lyell Immunopharma peak revenue was $84.7M in 2022.
- Lyell Immunopharma annual revenue for 2023 was 130.0K, -99.85% growth from 2022.
- Lyell Immunopharma annual revenue for 2024 was 61.0K, -53.08% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Lyell Immunopharma historical revenue
Lyell Immunopharma's peak revenue was $84.7M in 2022. The peak quarterly revenue was $48.4M in 2022(q4).
Lyell Immunopharma's revenue increased from $7.8m in 2020 to $61.0K currently. That's a -99.21% change in annual revenue.
Lyell Immunopharma annual revenue
Lyell Immunopharma annual revenue over time
| Fiscal year / year | Lyell Immunopharma revenue |
|---|---|
| 2020 | $7.8M |
| 2021 | $10.7M |
| 2022 | $84.7M |
| 2023 | $130,000 |
| 2024 | $61,000 |
Rate Lyell Immunopharma's financial transparency
Lyell Immunopharma annual growth
Lyell Immunopharma saw the greatest revenue growth in 2022, when revenue increased by 695.15%.
Lyell Immunopharma had the lowest revenue growth in 2021, when revenue changed by 37.31%.
Lyell Immunopharma annual growth rate over time
| Year | Lyell Immunopharma growth |
|---|---|
| 2021 | 37%↑ |
| 2022 | 695%↑ |
| 2023 | -100%↓ |
| 2024 | -53%↓ |
Lyell Immunopharma quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Lyell Immunopharma quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2021 | - | $2.6M | $2.8M | $2.8M |
| 2022 | $553,000 | $35.8M | $3,000 | $48.4M |
| 2023 | $65,000 | $27,000 | $25,000 | $13,000 |
| 2024 | $3,000 | $13,000 | $34,000 | $11,000 |
Lyell Immunopharma jobs nearby
Do you work at Lyell Immunopharma?
Is Lyell Immunopharma transparent about its revenue structure?
Lyell Immunopharma financing
Lyell Immunopharma received early financing of $493.0M on 2020-03-12.
| Series | Round size | Date |
|---|---|---|
| Series C | $493.0M | 03/2020 |
Lyell Immunopharma competitors
Lyell Immunopharma's top competitor, 10x Genomics, earned an annual revenue of $610.8M.
Lyell Immunopharma's smallest competitor is Instil Bio with revenue of $138.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Instil Bio | - | $138,000 | 175 | - |
| Pyxis Oncology | - | $552.7M | 75 | - |
| Oncternal Therapeutics | - | $785,000 | 13 | - |
| Bellicum Pharmaceuticals | - | $1.5M | 16 | - |
| PACT Pharma | - | $8.3M | 198 | - |
| 10x Genomics | - | $610.8M | 417 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Lyell Immunopharma highest paying jobs
Zippia gives an in-depth look into the details of Lyell Immunopharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Lyell Immunopharma. The employee data is based on information from people who have self-reported their past or current employments at Lyell Immunopharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Lyell Immunopharma. The data presented on this page does not represent the view of Lyell Immunopharma and its employees or that of Zippia.
Lyell Immunopharma may also be known as or be related to LYELL IMMUNOPHARMA, INC., Lyell Immunopharma and Lyell Immunopharma Inc.